Elorac

Specializes in developing, commercializing, and marketing dermatology products that treat skin diseases and disorders. The FDA and the European Union have granted orphan drug designation to Elorac for its naloxone lotion, used for the topical treatment of pruritus accompanying cutaneous t-cell lymphoma.

2013 Inc. 5000 Rank:
# 352
Leadership:
Jeff Bernstein
2012 Revenue:
$ 6.1 Million
3-Year Growth:
1,245%
Industry:
Health
Location:
Vernon HillsIL 
Founded:
2008
Employees:
14

MORE COMPANY INFORMATION